Shots: The collaboration follows the existing partnership b/w J&J and BARDA while the company expects to initiate the clinical studies of selected vaccine candidates by Sept’2020 with the anticipated first […]readmore
Tags : Development
Revance to get $25M upfront, milestone payments upon achievement of additional clinical, regulatory and sales targets, plus sales royalties in all relevant markets and will be finalized till Apr 30, […]readmore
Shots::sttohthshots: iBio enters a second statement of work under its MJDA with AzarGen, signed in 2018. The MJDA intends initial contract development and manufacturing of AzarGen’s biosimilars at iBio’s Bryan, […]readmore
Shots: Elevar to receive $20M up front, ~$678M as milestones based on the company’s achievement regarding the product along with royalties on sales of Apealea globally excluding Nordics, Russia, and […]readmore
Shots: Celltrion completes its first step of developing an antiviral treatment against COVID-19 and aims to launch a rapid self-testing diagnostic kit, that has the potential of providing results within […]readmore
Shots: The collaboration leads to the starting of pre-clinical testing of multiple vaccine prospects, intending to identify the vaccine candidate for clinical studies, by the month-end Janssen will utilize its AdVac […]readmore
The initiation of clinical study follows the US FDA’s acceptance of IND for TJM2 (TJ003234). The study will explore the potential of TJM2 and initially be conducted in the US […]readmore
Shots: Vir and NIAID will jointly identify and optimize combinations of Ab against coronaviruses, including SARS-CoV-2, SARS, and MERS along with Ab that may show effectiveness across additional types of […]readmore
Shots: CEPI to provide $4.4M to Novavax & the University of Oxford for accelerating the development of vaccines against COVID-19. CEPI has invested up to $23.7M in R&D of COVID-19 […]readmore
Shots: The collaboration will combine Iktos’ generative modeling AI technology with SRI’s SynFini synthetic chemistry platform to develop optimized compound & to facilitate the identification of drug therapies treating multiple […]readmore